The New Frontier of Host-Directed Therapies for Mycobacterium avium Complex

The New Frontier of Host-Directed Therapies for Mycobacterium avium Complex

Mycobacterium avium complex (MAC) is an increasingly important cause of morbidity and mortality, and is responsible for pulmonary infection in patients with underlying lung disease and disseminated disease in patients with AIDS. MAC has evolved various virulence strategies to subvert immune response...

Full description

Bibliographic Details
Main Authors: Nathan P. Crilly, Samuel K. Ayeh, Petros C. Karakousis
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Immunology
Subjects:
nontuberculous mycobacteria (NTM)
Mycobacterium avium complex
host-directed therapy
Mycobacterium tuberculosis
drug repurposing
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.623119/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2020.623119/full

Similar Items